Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Lichen Sclerosus Clinical Trials
Lichen Sclerosus clinical trials are recruiting across 6 cities. Here are the cities with the most active studies:
Lichen Sclerosus Trial Phases
2 research organizations are sponsoring lichen sclerosus trials.
About Lichen Sclerosus
Lichen sclerosus is a chronic inflammatory skin condition causing thin, white, patchy areas of skin, most commonly in the genital and anal areas. It is more common in postmenopausal women. Treatment includes potent topical corticosteroids and monitoring for rare malignant transformation.
Clinical trials are advancing new treatments for lichen sclerosus. Currently, 2 studies are recruiting a combined 752 participants across the United States. Research is being conducted by 2 organizations including LEO Pharma, Andrew T. Goldstein, MD.
2026 Lichen Sclerosus Research Landscape
As of July 2026, the lichen sclerosus clinical trial landscape includes 2 actively recruiting studies across 6 cities in the United States. These studies are collectively seeking 752 participants, with an average enrollment target of 376 per study.
The research spans multiple phases of development: 1 study is in PHASE3, 1 study is in PHASE1. The presence of Phase 3 trials indicates that some lichen sclerosus treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 2 different organizations, including LEO Pharma, Andrew T. Goldstein, MD.
Geographically, lichen sclerosus trials are most concentrated in Washington D.C., District of Columbia (2 trials); New York, New York (2 trials); Birmingham, Alabama (1 trial); Miami, Florida (1 trial); Tamarac, Florida (1 trial) and 1 other cities.
Featured Lichen Sclerosus Studies
Highlighted recruiting studies for lichen sclerosus, selected by enrollment size and research scope.
A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus
The main objective of the study is to evaluate the efficacy of twice daily applications of delgocitinib cream compared with cream vehicle in the treatment of adult participants with mild to severe lichen sclerosus (LS). The researchers are focusing on female participants because LS is more likely to affect females compared to males. The trial is conducted in 2 parts. Part 1 of the trial enrolls f...
StrataMGT in the Reduction of Vulvar Lichen Sclerosus (LS) Symptoms
This study is designed to evaluate the efficacy and safety of StrataMGT for the management of vulvar lichen sclerosus symptoms.
Frequently Asked Questions About Lichen Sclerosus Clinical Trials
Are there lichen sclerosus clinical trials near me?
Yes, there are 2 lichen sclerosus clinical trials currently recruiting across 6+ cities in the United States, including Washington D.C., District of Columbia; New York, New York; Birmingham, Alabama. Browse the studies above to find one at a location convenient for you.
How do I join a lichen sclerosus clinical trial?
To join a lichen sclerosus clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are lichen sclerosus clinical trials free?
Yes, participation in lichen sclerosus clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of lichen sclerosus treatments are being studied?
Current lichen sclerosus clinical trials are testing a range of approaches across PHASE3 (1 study), PHASE1 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 2 research organizations.
Is it safe to participate in lichen sclerosus clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 14, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 14, 2026 · Data from ClinicalTrials.gov